Official SEC submissions

ARS Pharmaceuticals SEC Filings

ARS Pharmaceuticals (SPRY) SEC filings, periodic reports and insider submission…

Direct answer

ARS Pharmaceuticals's latest SEC filing is 144.

It was filed on August 31, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free ARS Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

DEFA14A

Proxy statement

Filed:

DEFA14A

Open SEC documentView filing index

DEF 14A

Proxy statement

Filed:

Report date:

DEF 14A

Open SEC documentView filing index

10-K

Periodic report

Filed:

Report date:

10-K

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

Open SEC documentView filing index

Verified data

Recent filing categories
5
Recent filings
40
SEC CIK
0001671858
Latest filing date
August 31, 2026

Explore related company data

View the ARS Pharmaceuticals company profileView ARS Pharmaceuticals annual financials